Literature DB >> 12459317

Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors.

Ma del Carmen Mejía1, Samuel Navarro, Antonio Pellín, Amparo Ruíz, Victoria Castel, Antonio Llombart-Bosch.   

Abstract

BACKGROUND: Our objective was to study the proliferation and apoptotic process in 111 cases of neuroblastoma (NB) and to seek their relationship with other prognostic factors and survival.
METHODS: Immunohistochemistry following ABC peroxidase was carried out for PCNA, Ki-67, bcl-2, and p53 proteins. Apoptosis analysis was performed with in situ detection of chromosomal breakdown. Molecular detection of DNA ladders by electrophoresis and amplification of MYCN was studied with PCR and Southern blot. Statistical study was performed with Pearson chi(2) and Kruskal-Wallis tests and Cox regression.
RESULTS: Our results indicate that proliferative factors PCNA and Ki-67 were correlated to each other as well as to advanced stage and MYCN amplification. Regarding apoptosis, we found expression of bcl-2 protein in cases of NB without differentiation and advanced stages. p53 protein showed an inverse relation with bcl-2 and cell death measured by assay protein. In situ determination of apoptosis was found mainly in differentiated and stage 4s cases. Multivariate analysis revealed protein as the most independent risk factor of our study.
CONCLUSIONS: The study of cellular proliferation and apoptosis contributes with information of prognostic value that could be applied to the design of different protocols for treatment of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459317     DOI: 10.1016/s0188-4409(02)00384-3

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  1 in total

1.  Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification.

Authors:  Gisela Lundberg; Anders H Rosengren; Ulf Håkanson; Henrik Stewénius; Yuesheng Jin; Ylva Stewénius; Sven Påhlman; David Gisselsson
Journal:  PLoS One       Date:  2008-08-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.